Dyskeratosis congenita in an adolescent girl with associated choanal atresia

Pediatric Dermatology

Volumn 22, Issue 1, 2005, Pages 31-35

  Lener, Elizabeth V ^a   Tom, Wynnis L ^a   Cunningham, Bari B ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BONE MARROW DEPRESSION; CASE REPORT; CHOANA ATRESIA; CLINICAL FEATURE; DISEASE COURSE; DYSKERATOSIS CONGENITA; FEMALE; HUMAN; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SKIN BIOPSY; SKIN MANIFESTATION; X CHROMOSOME LINKAGE; X CHROMOSOME RECESSIVE INHERITANCE;

ADOLESCENT; CHOANAL ATRESIA; DYSKERATOSIS CONGENITA; FEMALE; HUMANS;

EID: 12944293006     PISSN: 07368046     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1470.2005.22107.x     Document Type: Article

References (24)

1. Zinnser F. Atrophia cutis reticularis cum pigmentatione, dystrophia unguium et leukoplakia oris, poikiloderma atrophicans vascularis Jacobi. Ikonographia Dermatologia 1906;5:219-223.
2. Engman MF. A unique case of reticular pigmentation of the skin with atrophy. Arch Dermatol Syphilol 1926;13:685-687.
3. Cole HN, Rauschkolb JE, Toomey J. Dyskeratosis congenita with pigmentation, dystrophia unguium, and leucokeratosis oris. Arch Dermatol Syphilol 1930;21:71-93.
4. Knight S, Vulliamy T, Copplestone A, et al. Dyskeratosis congenita (DC) registry: identification of new features of DC. Br J Haematol 1998;103(4):990-996.
5. Heiss NS, Knight SW, Vulliamy TJ, et al. X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions. Nat Genet 1998;19(1):32-38.
6. Drachtman RA, Alter BP. Dyskeratosis congenita. Dermatol Clin 1995;13(1):33-39.
7. Solder B, Weiss M, Jager A, et al. Dyskeratosis congenita: multisystemic disorder with special consideration of immunologic aspects. A review of the literature. Clin Pediatr (Phila) 1998;37(9):521-530.
8. Elliott AM, Graham GE, Bernstein M, et al. Dyskeratosis congenita: an autosomal recessive variant. Am J Med Genet 1999;83(3):178-182.
9. Ogden GR, Connor E, Chisholm DM. Dyskeratosis congenita: report of a case and review of the literature. Oral Surg Oral Med Oral Pathol 1988;65(5):586-591.
10. Reichel M, Grix AC, Isseroff RR. Dyskeratosis congenita associated with elevated fetal hemoglobin, X-linked ocular albinism, and juvenile-onset diabetes mellitus. Pediatr Dermatol 1992;9(2):103-106.
11. Dokal I. Dyskeratosis congenita: recent advances and future directions. J Pediatr Hematol Oncol 1999;21(5):344-350.
12. Dokal I. Dyskeratosis congenita in all its forms. Br J Haematol 2000;110(4):768-779.
13. Madan MS, Nandy NB, Saikhedkar R. Congenital choanal atresia in infants and children. Indian J Pediatr 1981;48(390):109-111.
14. Lowe LH, Booth TN, Joglar JM, et al. Midface anomalies in children. Radiographics 2000;20(4):907-922; quiz 1106-7, 1112.
15. Chia SH, Carvalho DS, Jaffe DM, et al. Unilateral choanal atresia in identical twins: case report and literature review. Int J Pediatr Otorhinolaryngol 2002;62(3):249-252.
16. Barwell J, Fox GF, Round J, et al. Choanal atresia: the result of maternal thyrotoxicosis or fetal carbimazole? Am J Med Genet 2002;111(1):55-56.
17. Morrison D, Rose EL, Smith AP, et al. Dyskeratosis congenita and nasopharyngeal atresia. J Laryngol Otol 1992;106(11):996-997.
18. Drachtman RA, Alter BP. Dyskeratosis congenita: clinical and genetic heterogeneity. Report of a new case and review of the literature. Am J Pediatr Hematol Oncol 1992;14(4):297-304.
19. Knight SW, Vulliamy TJ, Morgan B, et al. Identification of novel DKC1 mutations in patients with dyskeratosis congenita: implications for pathophysiology and diagnosis. Hum Genet 2001;108(4):299-303.
20. Mitchell JR, Wood E, Collins K. A telomerase component is defective in the human disease dyskeratosis congenita. Nature 1999;402(6761):551-555.
21. Mitchell JR, Cheng J, Collins K. A box H/ACA small nucleolar RNA-like domain at the human telomerase RNA-3′ end. Mol Cell Biol 1999;19(1):567-576.
22. Vulliamy TJ, Knight SW, Mason PJ, et al. Very short telomeres in the peripheral blood of patients with X-linked and autosomal dyskeratosis congenita. Blood Cells Mol Dis 2001;27(2):353-357.
23. Vulliamy T, Marrone A, Goldman F, et al. The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. Nature 2001;413(6854):432-435.
24. Alter BP, Gardner FH, Hall RE. Treatment of dyskeratosis congenita with granulocyte colony-stimulating factor and erythropoietin. Br J Haematol 1997;97(2):309-311.